In the present study, rescue experiments demonstrated that miR-302a-3p induced cell cycle arrest and promoted sensitivity of HCC cells to radiotherapy by targeting MCL1 expression, which was in accordance with the results of previous reports. This evidence concerns the gene MCL1 and hepatocellular carcinoma.